Beroni Group announced that it has appointed Dr. Richard Buchta as an independent non-executive director with effect from 1 July 2020. Dr. Richard Buchta has 30 years of experience in product development in pharmaceuticals and vaccines as well as in manufacturing and business development. He has developed and led project teams in the development of over 50 products, of which 25 have been launched in Australia and USA with 12 patents.